Simone Taddei

Dr. Simone Taddei

Department of Veterinary Science, University of Parma, Via del Taglio 10, 43126 Parma, Italy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Journal of Virological Methods
Verified
Journal Article
Closed access
GDGaetano Donofrio
Gaetano Donofrio
SCSandro Cavirani
Sandro Cavirani
STSimone Taddei
Simone Taddei
VSVicky Van Santen
Vicky Van Santen

10 April 2015 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
Francesco Di IanniFrancesco Di Ianni
Francesco Di Ianni
PDPier Luigi Dodi
Pier Luigi Dodi
CCClotilde Cabassi
Clotilde Cabassi
IPigor pelizzone
igor pelizzone
ASAndrea Sala
Andrea Sala
STSimone Taddei
Simone Taddei
In captive breed turtles and tortoises conjunctival disease is common. Our aim was to investigate the bacterial and fungal flora present in the eyes of healthy and pathological chelonians and to compare findings in turtles with those in tortoises. Samples were taken from the conjunctival sacs of 34, diseased and healthy, chelonians (18 tortoises and 16 turtles) and submitted to bacterial and fungal investigation. All samples showed bacterial growth. Thirteen animals (38%), harboured a single bacterial species as sole isolate and twenty-one animals (62%) harboured more than one species. Detection of multiple bacterial infection was clearly greater in tortoises compared to turtles. Most frequently isolated bacterial species were Bacillus spp. (13 isolates), Staphylococcus xylosus (10 isolates), Sphingomonas paucimobilis (6 isolates), Staphylococcus sciuri and Aeromonas hydrophila/caviae (each 5 isolates), Ochrobactrum anthropi (3 isolates), Citrobacter freundii, Enterobacter cloacae and Pseudomonas luteola (each 2 isolates). Only one isolate of Kocuria varians/rosea, Staphylococcus aureus, Staphylococcus auricularis, Staphylococcus haemolyticus, Staphylococcus lentus, Morganella morganii, Pasteurella multocida, Pasteurella pneumotropica/haemolytica, Proteus spp., Pseudomonas putida, Salmonella enterica ssp. arizonae, Stenotrophomonas maltophilia and Vibrio parahaemolyticus was evidenced. The presence in 8 animals of Mycoplasma spp. and in 1 animal with severe conjunctivitis of Chlamydia spp. was detected by PCR. Candida spp. was also isolated from two healthy animals. A clear predominance of Gram positive isolates in tortoises and Gram negative isolates in turtles was found. However, we cannot ascribe the observed difference to the diversity of animal species, as other factors, including especially different characteristics of the living environments, may play a role. Almost all bacterial species isolated may have clinical significance, mostly as opportunistic pathogens, both for humans and animals. That chelonians are often carrier of bacteria with zoonotic potential is a well-known fact, in particular with regard to Salmonella spp. Therefore, it is not surprising the detection of a strain of Salmonella enterica ssp. arizonae in the eye of one of the animals tested. Worthy of note is the finding of Chlamydia spp. in a severe case of conjunctivitis, though we cannot epidemiologically assess a cause-effect relationship between presence of chlamydia and disease.

1 November 2004 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Open access
PDF file
STSimone Taddei
Simone Taddei
CRChiara Robbi
Chiara Robbi
CCCamilla Cesena
Camilla Cesena
IRIlenia Rossi
Ilenia Rossi
ESEmiliana Schiano
Emiliana Schiano
SCSandro Cavirani
Sandro Cavirani
Three commercially available assays, designed to specifically detect the presence of Mycobacterium avium subsp. paratuberculosis (MAP) in fecal samples by IS900-PCR, were compared with a conventional culture method. Fecal samples from 100 dairy cows were tested. Fifty-four (67.5%) of 80 culture-positive samples were positive for an assay that detects MAP DNA by dot spot hybridization of polymerase chain reaction products (kit A), 48 (60%) were positive by an assay using ethidium bromide staining for agar gel visualization of amplification products (kit B), and 49 (61.3%) were positive by an assay in which amplified products are detected by a colorimetric detection system (kit C). Relative sensitivity of all tests increased in proportion to the presence of MAP in fecal samples. Specificity was 100% based on results from 20 culture-negative samples from an MAP-free herd.

1 November 2008 in Vaccine
Verified
Journal Article
Closed access
GDGaetano Donofrio
Gaetano Donofrio
CSC. Sartori
C. Sartori
VFvalentina franceschi
valentina franceschi
ACA. Capocefalo
A. Capocefalo
SCSandro Cavirani
Sandro Cavirani
CFC.F. Flammini
C.F. Flammini

1 January 2014 in Italian Journal of Animal Science
Verified
Journal Article
Open access
PDF file
CBCarla Bresciani
Carla Bresciani
CCClotilde S. Cabassi
Clotilde S. Cabassi
GMGiorgio Morini
Giorgio Morini
STSimone Taddei
Simone Taddei
Ruggero BettiniRuggero Bettini
Ruggero Bettini
EPEnrico Parmigiani
Enrico Parmigiani
Boar semen bacterial contamination in Italy and antibiotic efficacy in a modified extender

18 October 2007 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
GDGaetano Donofrio
Gaetano Donofrio
CSChiara Sartori
Chiara Sartori
LRLara Ravanetti
Lara Ravanetti
SCSandro Cavirani
Sandro Cavirani
LGLaurent Gillet
Laurent Gillet
CFCesidio Filippo Flammini
Cesidio Filippo Flammini
The biological characteristics of BoHV-4 make it a good candidate as a gene delivery vector for vaccination purposes. These characteristics include little or no pathogenicity, unlikely oncogenicity, the capability to accommodate large amounts of foreign genetic material, the ability to infect several cell types from different animal species, and the ability to maintain transgene expression in both undifferentiated and differentiated cells. A recombinant bovine herpesvirus 4 (BoHV-4CMV-IgKE2-14ΔTK) expressing an enhanced secreted form of the bovine viral diarrhea virus (BVDV) structural glycoprotein E2 (gE2-14), obtained by the removal of the putative transmembrane domain and addition of a 14 amino acids peptide at its carboxyl terminal and an immunoglobulin K signal peptide to the amino terminal, was successfully constructed using a Recombineering (recombination -mediated genetic engineering) approach on BoHV-4 cloned as bacterial artificial chromosome. The galactokinase – based recombineering system was modified by the introduction of a kanamycin expression cassette and a kanamycin selection step that allowed a significant reduction of the untargeted background clones. BoHV-4CMV-IgKE2-14ΔTK infected cell lines highly expressed gE2-14, which maintained native antigenic properties in a serum neutralization inhibition test. When rabbits and sheep were immunized with BoHV-4CMV-IgKE2-14ΔTK, high levels of serum neutralized antibodies against BVDV were generated. This work highlights the engineerization of BoHV-4 genome as a vector for vaccine purposes and may provide the basis for BVDV vaccination exploiting the BoHV-4- based vector that delivers an improved secreted version of the BVDV structural glycoprotein E2.